Additionally, HDAC8 inhibitors have been shown to reduce ventricular hypertrophy and fibrosis, as well as alleviate symptoms of heart failure (Zhao et al., 2021; 2022). This evidence concerns the gene HDAC8 and Ventricular hypertrophy.